BEOVU

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, UK.

Active ingredients

The drug BEOVU contains one active pharmaceutical ingredient (API):

1	Brolucizumab UNII XSZ53G39H5 - BROLUCIZUMAB
	Brolucizumab is a humanised monoclonal single chain Fv (scFv) antibody fragment with a molecular weight of ~26 kDa. Brolucizumab binds with high affinity to VEGF-A isoforms, thereby preventing binding of VEGF-A to its receptors VEGFR-1 and VEGFR-2. By inhibiting VEGF-A binding, brolucizumab suppresses endothelial cell proliferation, thereby reducing pathological neovascularisation and decreasing vascular permeability.
	Read more about Brolucizumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BEOVU Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)
BEOVU Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01LA06		S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02496976
EE	Ravimiamet	1811393, 1811405
FI	Lääkealan turvallisuus- ja kehittämiskeskus	113179
GB	Medicines & Healthcare Products Regulatory Agency	381073
HK	Department of Health Drug Office	67008, 67009
IL	מִשְׂרַד הַבְּרִיאוּת	8761
JP	医薬品医療機器総合機構	1319406G1024
LT	Valstybinė vaistų kontrolės tarnyba	1089424, 1089425
NL	Z-Index G-Standaard, PRK	201790
NZ	Medicines and Medical Devices Safety Authority	21469, 21470
PL	Rejestru Produktów Leczniczych	100432311
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66674001
US	FDA, National Drug Code	0078-0827